CAMP4 Therapeutics Funding: $175M Raised, Series A (2021)
CAMP4 Therapeutics is a Biotech company based in Cambridge. It has raised $175M in total funding. Latest round: Series A.
CAMP4 Therapeutics funding overview
CAMP4 Therapeutics is a Biotech company based in Cambridge. CAMP4 Therapeutics has raised $175M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2021. The round record for CAMP4 Therapeutics runs through 2021; nothing later has been disclosed.
CAMP4 Therapeutics at a glance
Total raised
$175M
Latest round
Series A
Latest round date
June 2021
Industry
Biotech
Headquarters
Cambridge
Frequently asked about CAMP4 Therapeutics funding
How much has CAMP4 Therapeutics raised?
CAMP4 Therapeutics has raised $175M in total disclosed funding across the rounds on record.
Who has invested in CAMP4 Therapeutics?
No investors are named on the public record for CAMP4 Therapeutics yet.
What was the latest CAMP4 Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2021.
Where is CAMP4 Therapeutics based?
CAMP4 Therapeutics is based in Cambridge.
What sector does CAMP4 Therapeutics operate in?
CAMP4 Therapeutics is tracked under Biotech from Cambridge, with $175M in disclosed funding.
When did CAMP4 Therapeutics last raise?
The last disclosed CAMP4 Therapeutics round closed in June 2021 at Series A.
We update the CAMP4 Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
